MedPath

Effect of Deep Brain Stimulation on Gastrointestinal (GI) Motility

Not Applicable
Completed
Conditions
Parkinson's Disease
Interventions
Device: Deep brain stimulation
Registration Number
NCT01081457
Lead Sponsor
University Hospital, Rouen
Brief Summary

Parkinson's disease is characterized by extra-pyramidal symptoms as well as digestive involvement with gastrointestinal motility (GI) impairment. Deep brain stimulation has been recently developed as a successful treatment for extrapyramidal symptoms. In addition, preliminary reports suggest that this therapy might be successful to relieve GI symptoms as well. The aim of this study is therefore to assess the effect of deep brain stimulation on GI voluntary as well as involuntary motility.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria
  • patient over 18 yo
  • patient with Parkinson's disease implanted for deep brain stimulation
  • patient responders to deep brain stimulation (UPDRS improved by at least 40%)
  • patient covered by the french health care system
  • patient not taking anti-parkinsonian medication the day before evaluation
  • French speaking
Exclusion Criteria
  • patient below 18 yo
  • pregnancy
  • Severe psychiatric or cognitive disorders
  • diabetes mellitus
  • morbid obesity
  • compulsive eating disorders
  • diffuse GI motility impairment (except Parkinson's disease)
  • other evolutive neurologic disorders
  • previous history of significant GI resection
  • inability to swallow or defecate when asked

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
ONDeep brain stimulationStimulator switched ON
OFFDeep brain stimulationStimulator switched OFF
Primary Outcome Measures
NameTimeMethod
Anal pressure2 hours
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Rouen University Hospital

šŸ‡«šŸ‡·

Rouen, France

Ā© Copyright 2025. All Rights Reserved by MedPath